PharmAsia Summit – Shanghai

Monday, October 21 – Wednesday, October 23 2013

Location: Grand Hyatt Shanghai, Shanghai, China

At the PharmAsia Summit – Shanghai, Elsevier and BayHelix will focus on new R&D and commercial models in a rapidly changing China. Given demographic changes and China's massive health care reforms, opportunities abound - but so do potential pitfalls. Tapping the unmet medical need present in China provides Pharma with one of its few growth bright spots. But achieving this growth will require new models and flexibility: smaller cities are now growing faster than Tier I cities presenting logistical challenges; off-patent medications are under severe pricing pressure, which could limit the widespread uptake of branded generics. While support for biopharma innovation is a major government goal, so is curbing healthcare inflation. How can Pharmas collaborate and thrive in this environment?

At the PharmAsia Summit, top industry leaders from China and the West will discuss new growth models for China via a series of case studies, panels and keynotes.

Share MassBio